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Abstract
Gene expression measurements detailing mRNA quantities are widely employed in molecular biology and are increasingly
important in diagnostic fields. Reverse transcription (RT), necessary for generating complementary DNA, can be both
inefficient and imprecise, but remains a quintessential RNA analysis tool using qPCR. This study developed a Transcriptomic
Calibration Material and assessed the RT reaction using digital (d)PCR for RNA measurement. While many studies
characterise dPCR capabilities for DNA quantification, less work has been performed investigating similar parameters using
RT-dPCR for RNA analysis. RT-dPCR measurement using three, one-step RT-qPCR kits was evaluated using single and
multiplex formats when measuring endogenous and synthetic RNAs. The best performing kit was compared to UV
quantification and sensitivity and technical reproducibility investigated. Our results demonstrate assay and kit dependent
RT-dPCR measurements differed significantly compared to UV quantification. Different values were reported by different kits
for each target, despite evaluation of identical samples using the same instrument. RT-dPCR did not display the strong inter-
assay agreement previously described when analysing DNA. This study demonstrates that, as with DNA measurement, RT-
dPCR is capable of accurate quantification of low copy RNA targets, but the results are both kit and target dependent
supporting the need for calibration controls.
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Introduction
Measuring RNA by reverse transcription real-time quantitative
PCR (RT-qPCR) is an established approach for investigating gene
expression and viral diagnostics. It is well known that the RT step,
required to convert RNA to complementary DNA (cDNA), is
imprecise and that different reverse transcriptase enzymes (RTase)
can work with considerably different efficiencies [1]. Many of the
issues associated with differing RTase efficiencies may be
sidestepped by taking advantage of the linear nature of RT and
performing relative quantification, with the results expressed as
fold changes, or by comparing to a standard curve that is equally
affected by the limitations of the RT.
Digital (d)PCR is continuing to gain recognition in the field as
an extremely precise and reproducible methodology offering the
potential for accurate, robust and highly sensitive measurement
without the need for a standard curve [2]. Much work has already
been done to meticulously evaluate this technique for DNA
molecular measurement [3,4,5,6,7,8]. However, a comprehensive
evaluation is yet to be established for RNA. dPCR expands the
long established premise of molecular quantification by qPCR
through facilitating measurement of individual target molecules.
Molecules are isolated by limiting dilution and partitioning, before
being individually amplified by PCR [7,9]. Each reaction is then
analysed separately. A count of positive partitions may then be
used to calculate, using Poisson statistics, an absolute count of
target molecules present in the sample [10]. As a result, the need
for a calibration curve to assign a value is argued to be unnecessary
[4,5,7,11,12,13], and this fact has quickly led to the notion that
dPCR is calibration free [2]. dPCR may also offer the potential to
maximise the accuracy, sensitivity and reproducibility of RNA
measurements, for capabilities such as diagnostic mRNA profiling,
biomarker analysis and monitoring of viral load.
While this may be true, many studies have demonstrated that
the variability inherent in the RT component of the process far
outweighs that observed from the PCR step when performing
qPCR [14,15,16]. Quantification sensitivity differences reported
between one-step and two-step RT-qPCR for low copy targets or
low concentration samples such as single cells [17,18,19,20], may
in part be attributed to gene-specific priming in one-step protocols
(as opposed to random hexamers or oligo (dT) commonly used in
two-step protocols). An additional consideration when performing
RT-dPCR is sample partitioning. For two-step protocols, the
cDNA is produced before sample partitioning for dPCR. This
therefore must rely on the assumption that the RT step is linear
and so the number of cDNA molecules accurately represents the
initial number of target RNA molecules. If this is not the case,
significant bias may be introduced. Alternatively for one-step
protocols, the RNA population is partitioned prior to RT and as
such, one RNA target molecule is represented by one positive
partition (pending successful amplification). One-step RT-dPCR
protocols therefore reduce the potential for bias in this capacity.
In this study we investigated how this characteristic of the RT
might affect cDNA production and ultimately influence the dPCR
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measurement by performing RNA analysis by RT-dPCR and
assessing the repeatability, linearity and sensitivity of dPCR
measurement. We prepared a Transcriptomic Calibration Mate-
rial (TCM) and measured both synthetic and endogenous targets,
comparing RT-dPCR analysis to UV, and evaluated how different
assays and commercially available one-step RT-qPCR kits
perform using both endogenous targets and synthetic process
controls.
Materials and Methods
LoBindH tubes were employed throughout this study (Eppen-
dorf, Cambridge, UK). Primer and probe sequences for dPCR
were designed in-house using Primer Express, software version 3
(Life Technologies, Paisley, UK) and obtained from Sigma
(Dorset, UK). Primers/assays were positioned across different
RNA secondary structure motifs (predicted using MFOLD
[21,22], representing both tightly folded and more open regions,
depending on the target (Figure S1). Sequences, gene accession
numbers and assay concentrations are outlined in Table S1.
ERCC RNA concentration and copy number estimates are
summarised in Table S2. Assay positions within the respective
transcripts are detailed in Table S3. Total yeast RNA [from bakers
yeast (Saccharomyces cerevisiae), Sigma] at 25 ng/reaction was used as
carrier in this study. All samples were diluted using RNA Storage
Solution, RSS (Life Technologies), unless otherwise stated.
Synthetic RNA Transcripts
Six synthetic (ERCC developed targets; External RNA Control
Consortium) RNA transcripts (ERCC-00013, 200025, 200042,
200099, 200113, and 200171) were selected for investigation
(supplied in plasmid DNA format, courtesy of Dr Marc Salit,
NIST, USA). For brevity, the ERCCs shall be subsequently
identified without the preceding zeros. Concentrations of plasmid
were assigned by the supplier using UV spectrophotometry and
converted to copy number using published methods [23]. Copy
number conversions were performed using the appropriate
extinction coefficient values for dsDNA (50 ng-cm/mL) or RNA
(40 ng-cm/mL).
ERCC RNA was prepared from the corresponding plasmid
DNA, as described previously [24] In vitro transcription (IVT)
performed using MEGAscriptH T7 Kit (Life Technologies): 37uC
overnight incubation, with Turbo DNase treatment. IVT ERCC
RNA concentrations and insert sizes were subsequently estimated
using Nanodrop UV spectrophotometry (Thermo Scientific,
Massachusetts, USA) and 2100 Bioanalyzer (Agilent, West
Lothian, United Kingdom), respectively. 2100 Bioanalyzer data
may be found in Figure S2. Samples were diluted to approximately
1 ng/mL in RSS and aliquots stored at 280uC. Concentrations
and copy number estimates are reported in Table S2.
Cell Lines: Endogenous Targets
Three human cell lines were employed for production of
complex background material for endogenous target selection;
Hep-G2 (organ: liver, disease: hepatocellular carcinoma), SaOS-2
(organ: bone, disease: osteosarcoma) and Hs 683 (organ: brain,
disease: glioma), (all cell lines from ATCC, Teddington, UK).
Culturing details given in Appendix S1.
Based on confluency and cell size, eight to fourteen flasks were
prepared for each cell type, as outlined in Appendix S1. Medium
was removed, cells washed in Hanks Balanced Salt Solution
(HBSS; PAA Laboratories, Somerset, UK) and TRIzol (Sigma)
added directly to cell monolayers (17.5 mL per T-175 flask) and
passed three times over the entire surface of the flask to ensure cell
lysis. Lysates were transferred to 50 mL round-bottomed Falcon
tubes and stored at 280uC until RNA extraction. Replicate T-175
flasks (one per cell line used) generated at the same time and under
the same conditions were used for cell enumeration and viability
estimates using a Vi-Cell (Beckman Coulter, High Wycombe,
UK). For cell counting, cells were detached post HBSS wash using
5 mL Trypsin/EDTA (Sigma) for 5 min at 37uC and neutralised
with 5 mL culture medium before Vi-Cell analysis.
Total RNA was extracted from cell lysates by following the
standard TRIzol protocol (Invitrogen), details given in Appendix
S1. Total RNA solutions were then treated with recombinant
(r)DNase I (Life Technologies), as per manufacturer’s protocol (1 U
rDNase I reagent added per 4 mg of total RNA, incubated at 37uC
for 30 min). These preparations were then purified using RNeasy
midi kit (Qiagen), assessed for quantity (yield; Nanodrop), and
subsequently pooled (per cell-type).
Following total RNA extraction, DNase treatment and clean-up,
pooled cell-line RNA samples were subjected to standard quality
metrics for concentration and integrity (Nanodrop and 2100
Bioanalyzer, respectively). Neat samples (resuspended following
clean-up in nuclease-free water, between 110–700 ng/mL) were
then stored in aliquots at 280uC.
Preparation of Transcriptomic Calibration Material
Pooled cell line RNA stocks were diluted in RSS to 250 ng/mL
(Hep-G2 and Hs683) or 100 ng/mL (SaOS-2), and the complex
background material prepared by mixing different proportions of
each cell line RNA to a final concentration of 50 ng/mL
(Proportions: 0.755 Hep-G2, 0.205 Hs 683, 0.04 SaOS-2). A
mix containing all six ERCC transcripts was spiked into the mixed
ratio cell line solution, at approximately 1.0E+06 copies/mL (final
concentration), to produce the Transcriptomic Calibration Mate-
rial (TCM) for analysis. The TCM solution was aliquoted (150 mL)
to generate 245 replicate units prior to storage at 280uC.
RT-dPCR Analysis
dPCR experiments were performed using the Fluidigm Biomark
platform. Both 12.765 and 48.770 chip formats were utilised.
Assays were first optimised using the Prism 7900 HT real-time
PCR system (Life Technologies) before transfer to the Biomark.
One-step RT-dPCR utilised AgPath-ID one-step RT-PCR
reagents (Ambion). Master reactions comprised RT-PCR buffer/
master mix (16), RT enzyme (16), GE sample loading reagent
(16, Fluidigm), sequence-specific gene assay (Table S1. RT
priming was gene-specific due to one-step process), 25 ng/reaction
Yeast total RNA carrier and RNA at various concentrations
(Table 1). These master reactions were added to dPCR chip inlets,
a proportion of which is loaded per panel (see Appendix S2 for
volumetric details). Samples were analysed in triplicate (kit
comparison) or replicates of six panels (Quantification Sensitivity
experiment). Reaction mix (i.e. master mix, gene specific assay and
RNA) was loaded into sample inlets and delivered to nanolitre
partitions by an integrated fluidic circuit controller. Thermal
cycling conditions: (RT) 45uC for 30 min, (RTase inactivate/
denature) 95uC for 15 min, (PCR) 40 cycles 95uC for 15 s and
60uC for 60 s. Analysis was performed utilising dPCR analysis
software (Fluidigm), version 3.0.2. dPCR calculations are ex-
plained in further detail in the Appendix S2. Adherence to the
MIQE guidelines is detailed in Table S4.
A count of partitions showing positive amplification can be
made and an absolute target concentration elucidated. ‘‘Estimated
copies’’ or ‘‘Copies per panel’’ refer to the number of targets on
the panel following a Poisson correction, to account for the fact
that some positive partitions will contain more than one molecule.
Digital PCR Quantification of RNA
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As the number of positive partitions increases, so does the
probability that some partitions will contain more than one target
molecule. See Appendix S2 for calculations. Examples of dPCR
output are provided in Figure S3.
For one-step kit comparison, two further commercial kits were
evaluated; Quantitect Probe one-step RT-PCR Kit (Qiagen) and
Superscript III Platinum one-step RT-qPCR system w/ROX
(Invitrogen). Both the Ambion (Multiscribe) and Invitrogen
(Superscript III) RTases are derived from Moloney murine
leukemia virus (MMLV) RTase. Alternatively, the Qiagen
(Omniscript and Sensiscript) RTases are derived from a unique
source (undisclosed). The Qiagen RTases maintain RNase H
activity, while the Ambion and Invitrogen RTases are claimed to
have reduced RNase H activity.
One-Step RT-qPCR Kit Comparison by dPCR
Initially, quantification was assessed for two external (ERCC-25
and ERCC-99) targets in both uniplex and duplex formats,
between the three commercial one-step RT-qPCR kits: AgPath ID
(Ambion), Quantitect (Qiagen) and Superscript III (Invitrogen).
RT-dPCR was performed using Fluidigm Biomark 12.765 dPCR
chips, n = 1 panel, plus three replicate experiments. Sample was
diluted to approximately 1896 copies per panel (or 2062 copies/
mL added to master mix), based on UV estimates. Following this,
ERCC-25 and ERCC-99, plus two endogenous (UBC and
MMP1) targets were compared between the kits. These assays
were analysed in duplex: ERCC-25 with ERCC-99 (duplex A),
UBC with MMP1 (duplex B), and ERCC-25 with UBC (duplex
C). Sample was diluted to approximately 1886 copies per panel (or
1640 copies/mL added to master mix, for ERCC targets), based on
UV estimates. RT-dPCR was performed using Fluidigm Biomark
12.765 dPCR chips, n = 3 replicate panels, plus two replicate
experiments.
Comparison between dPCR and UV Measurement
Measurement variability of six ERCC targets was tested using
RT-dPCR evaluated as above (AgPath ID kit, Ambion). ERCC
targets were spiked into cell line-derived total RNA at approxi-
mately 1.0E+06 copies/mL (estimated by UV), enabling evaluation
of potential assay bias. Sample was diluted to approximately 200–
400 copies per panel. RT-dPCR was performed using Fluidigm
Biomark 48.770 dPCR chips, n = 3 replicate experiments. Assays
were analysed in uniplex.
RT-dPCR Quantification Sensitivity
An evaluation of RT-dPCR quantification sensitivity was
performed using ERCC-25 and ERCC-99 assays. Based on UV
estimated values, sample was diluted in 0.5% Tween 20 (Sigma) to
approximately 500, 250, 100, 50, 25, 10 and 5 copies per panel
(equivalent to 3077, 1538, 615, 308, 154, 62 and 18 copies/mL,
respectively). Volumetric dilutions were performed independently
for each dilution, rather than sequentially, to avoid volumetric
error propagation during dilution steps. RT-dPCR was performed
using Fluidigm Biomark 48.770 dPCR chips, n = 6 panels per
dilution, plus three replicate experiments. Assays were analysed in
duplex.
Statistical Methods
All statistical analyses were performed using MS Excel 2007 and
the R statistical programming environment (http://www.r-project.
org/). All data sets incorporated ANOVA calculations.
One-Step RT-qPCR kit comparison by dPCR. The square
of the copy numbers was needed in order to stabilise the difference
in variance between groups. Standard uncertainties have 2 degrees
of freedom, converted to expanded uncertainty with coverage
factor (k) = 4.3.
Comparison between dPCR and UV
measurement. Weighted regression was used to stabilise the
different variance between groups. Standard uncertainty estimates
were made to 3 significant figures and have 2 degrees of freedom,
with k = 4.3 to convert to expanded uncertainties. Only dispersion
due to plate-to-plate variation was included. dPCR plate-to-plate
variability was estimated by pooling the data for all six ERCCs.
The relative standard deviation was approximately 7.59% (46,000
copies) with 12 degrees of freedom (18 data points minus the six
estimated group means).
RT-dPCR quantification sensitivity. A linear mixed model
fit was used with experiment as random effect. Additionally, an
ANOVA was applied removing experiment from the model and
applying a classical fixed effect linear model fit (with only assay
and dilution as factors).
Endogenous versus synthetic targets. The analysis was
split into four groups, one per assay. The square root of the copy
numbers was needed in order to stabilise the difference in variance
between groups. The Qiagen kit always resulted in zero positive
partitions for MMP1, which was therefore removed from the data
set.
Results
One-Step RT-qPCR Kit Comparison by dPCR
Three commercially available kits were compared for quanti-
tative performance by RT-dPCR. The three kits were initially
assessed using both uniplex and duplex formats for quantification
of two synthetic RNA targets: ERCC-25 and ERCC-99 (Figure 1).
The choice of kit significantly affected RNA quantification
(p,0.0001) with the Ambion kit consistently yielding the highest
Table 1. Sample dilutions analysed. Derived by UV spectrophotometry (ERCCs only).
Experiment Assay RNA target copies per panel* Replicates
One-Step RT-qPCR Kit Comparison by dPCR ERCC-25 and ERCC-99 ,1896 1 panel/assay, 3 replicate chips
Comparison between dPCR and UV Measurement All six ERCCs ,200–400 3 panels/assay
RT-dPCR Quantification Sensitivity ERCC-25 and ERCC-99 ,500, 250 100, 50, 25, 10 or 5 6 panels/dilution/assay, 2 replicate
chips
Evaluation of Reverse Transcriptases ERCC-25, ERCC-99, UBC and MMP1 ,1886 3 panels/assay duplex, 2 replicate
chips
*Dilutions are quoted based on RNA copies per dPCR panel. RNA concentrations were estimated by UV and converted to copy number using published methods [23].
No template controls (NTCs) for every experiment resulted in no amplified signal observed.
doi:10.1371/journal.pone.0075296.t001
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signal. A significant difference was also observed between uniplex
and duplex formats for the Qiagen (ERCC-25 p= 0.045) and
Invitrogen (ERCC-25 p= 0.025, ERCC-99 p= 0.019) kits but not
the one supplied by Ambion (ERCC-25 p= 0.347, ERCC-99
p= 0.736), (Qiagen ERCC-99 p= 1.000); however this difference
was considerably smaller than the inter kit differences (Figure 1).
Consistent ratios for ERCC-25:ERCC-99 between uniplex and
duplex measurements were not maintained between kits suggest-
ing an assay-dependent as well as a kit associated difference
(Table 2). The ERCC-99 assay consistently resulted in lower
estimated copies than that for ERCC-25 (with all kits), despite
being added at the same concentration; as estimated by UV.
Comparison Between dPCR and UV Measurement
To investigate this disparity further, RT-dPCR measurements
using the Ambion kit were compared when measuring a further
four ERCC targets (all six present within the TCM) (Figure 2).
dPCR estimates of ERCC transcript quantities were on average
40% lower than when measured by UV (p,0.0001). Bioanalyzer
quantification for all six synthetic targets was comparable to
nanodrop concentration estimates (p = 0.660, with an average
difference between the two approaches of 1.02). The differences
observed in absolute quantification between dPCR and UV were
assay-specific (Figure 2). The number of dPCR positive partitions
for ERCC-25 was closest to UV at 77.41% agreement, whereas
ERCC-99 displayed the lowest agreement at 50.45%, as
previously described. Furthermore, there was no inter-plate
difference observed despite 5–6 days between runs.
Linearity and Sensitivity of RT-dPCR
An additional aim was to identify RT-dPCR sensitivity and
linearity of measurement for low copy targets. This was performed
utilising the Ambion kit alone, due to its superior capabilities
throughout our initial analyses. A dilution series of two synthetic
RNA targets, ERCC-25 and ERCC-99, were analysed in duplex
(Figure 3). Dilutions were performed based on UV evaluation,
using dH2O 0.5% v/v Tween 20 as diluent, to generate samples
equating to approximately 500, 250, 100, 50, 25, 10 or 5 copies/
panel.
There was a significant difference identified between the two
targets agreement with UV values, p,0.0001 (Figure 3A & B),
which concurred with our previous observations (Figure 2). Both
ERCC-25 and ERCC-99 displayed linear quantification capabil-
ities, with good precision (CVs of less than 10%) achievable down
to 50 UV assigned copies (Figure 3C).
Further Evaluation of Reverse Transcriptase’s Targeting
Endogenous Transcripts
In order to investigate the applicability of our findings to real
samples, the same three, one-step RT-qPCR kits were tested to
compare measurement of endogenous targets alongside external
controls in various duplex combinations in the TCM (Figure 4).
Again for each target, there was a significant effect of kit on dPCR
quantification (all p values ,0.0001). For endogenous targets, the
Ambion kit yielded the highest quantification values, as previously
observed with external controls: although the variability observed
for UBC was higher.
To establish whether different plex pairings influenced RT-
dPCR results, duplex reactions were performed pairing different
targets (Duplex A: ERCC-25+ ERCC-99. Duplex B: MMP1+
UBC. Duplex C: ERCC-25+ UBC). As observed above, there was
a significant difference between the kits, but no significant
difference observed in dPCR values between ERCC-25 or UBC
when assessed in different duplex reactions using the Ambion
reagents (ABC), p = 0.061 and 0.92, respectively. Therefore, for
these targets, assays did not influence the quantification result of
their duplex partners.
Discussion
In this study we used a Transcriptomic Calibration Material
(TCM) containing synthetic RNA transcripts in a complex
background made of mixtures of human cell line total RNA. This
was used to both evaluate dPCR measurement and demonstrate
the applicability of the TCM for supporting accurate RNA
enumeration by RT-dPCR.
The findings from the one-step kit comparison by dPCR
(Figure 1, Table 2) indicate that there can be large numbers of
RNA molecules present within the dPCR partitions that are not
being detected with dPCR because either they are not converted
to cDNA or are being converted to cDNA but not being amplified
by the PCR: and that this is kit and/or transcript dependent.
Furthermore, the UV measurement may potentially overestimate
the initial valuation. This is explored in more detail below.
The analysis method was shown to significantly affect the RNA
quantification result. There may be a number of reasons
explaining the significant difference observed between dPCR
and UV methodologies. While dPCR makes an absolute count of
specific amplified cDNA target molecules, UV cannot discriminate
between nucleic acid species, non-target RNA and fragmented/
degraded/non-amplifiable targets [7,25,26,27,28,29]. This could
contribute to the consistent increased RNA concentration
estimated by UV. However, the concordance between UV and
the 2100 Bioanalyzer suggest these additional factors are not
playing a major role. Another explanation for the discrepancy is
that the RT-dPCR measurement value may be underestimating
the true concentration. Quantification of RNA reflects only the
number of target cDNA molecules converted from the original
RNA. This may or may not give an accurate estimate for the
original concentration of the RNA molecules of interest [30]. Not
only have we shown here the potential for RT sensitivity and
variability to affect dPCR estimation, as previously reported when
using qPCR [1,31], but our previous studies have shown similar
disparity between dPCR and UV valuation when measuring DNA
targets [7], suggesting the PCR step in the RT-dPCR may also
contribute to the observed differences.
Figure 1. One-step kit comparison. Three different one-step RT-
qPCR kits were compared in both uniplex and duplex formats, by dPCR.
Two external targets, ERCC-25 and ERCC-99 were analysed. Error bars:
95% Confidence intervals. n = 3 replicate panels. Equivalent UV
estimates: ERCC-25 1185 copies/panel, 95% CI 17.34. ERCC-99 1185
copies/panel, 95% CI 26.19.
doi:10.1371/journal.pone.0075296.g001
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Our linearity and sensitivity data clearly show a pattern of
increased variability with the increase of dilution factor below 50–
100 estimated copies. We have previously demonstrated that when
analysing DNA targets, dPCR is highly precise down to 16 copies/
panel [7] suggesting RNA measurement is more variable.
The magnitude of the quantification difference between kits was
not consistent between different targets, both synthetic and
endogenous, suggesting an additional assay specific and kit
associated bias. There was a greater difference between kits when
measuring endogenous targets than for synthetic targets. Further-
more, both Invitrogen (1 positive partition) and Qiagen (0 positive
partitions) kits were unable to provide satisfactory quantification
values for MMP1 despite being measured with six replicates
totalling some 4590 reactions. However, as the Ambion kit only
measured on average 112 MMP1 positive partitions, it would
suggest that this transcript was below the limit of detection for the
two former kits. Measurement, or specifically enzyme, efficiency/
sensitivity is an important consideration when measuring low
abundance RNA targets, in order to avoid false negative results
and our data suggests that choice of kit is crucial for ensuring the
most sensitive result when performing RT-dPCR. It should also be
noted that while MMP1 target was present at low abundance in
Table 2. Three one-step kit comparison with uniplex and duplex formats.
Method Format ERCC- Positive Partitions Copies per panel* Ratio{ Standard Uncertainty
Ambion Duplex 25 627 1316 1.37 0.051
99 546 959
Uniplex 25 639 1383 1.47 0.076
99 541 944
Invitrogen Duplex 25 295 373 3.31 0.223
99 104 113
Uniplex 25 335 442 5.18 0.262
99 81 85
Qiagen Duplex 25 68 71 4.22 0.588
99 17 17
Uniplex 25 89 95 5.57 0.906
99 17 17
*Copies per panel calculated from the number of positive partitions using the Poisson correction.
{Ratio of ERCC-25/ERCC-99 dPCR values with standard uncertainties. Ratios calculated using copies per panel. Standard uncertainty calculated by dividing the standard
deviation by the square root of n (number of replicate measurements).
doi:10.1371/journal.pone.0075296.t002
Figure 2. dPCR versus UV quantification. Six external targets (ERCC-13,225,242,299,2113 and2171) were assessed by both one-step dPCR,
utilising the Ambion one-step RT-qPCR kit, and UV measurement. Error bars: 95% Confidence intervals. n = 3 replicate dPCR experiments or UV
measurements.
doi:10.1371/journal.pone.0075296.g002
Digital PCR Quantification of RNA
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Figure 3. dPCR sensitivity for RNA measurement. Assessment of RT-dPCR quantification sensitivity, using independent dilutions and
quantifying ERCC-25 and ERCC-99 external targets in a duplex format. n = 6 panels per dilution, plus two replicate experiments. UV data based on
Digital PCR Quantification of RNA
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the dilutions tested, evaluation of a more concentrated sample may
circumvent the sensitivity issues associated with the two kits.
Therefore, this must also be considered when validating protocols,
and where possible, low copy measurements should be avoided.
Causes of Differing RT-dPCR Results
One of the most striking findings of this study is the large inter
assay and inter kit difference in the estimated copies for a given
target. There are a number of potential causes for these
observations. It is clear from our data that some, if not all, of
the kits analysed during this study were not measuring all the RNA
molecules that were present. There may be a number of different
reasons for this. The assumption that DNA measurement by
dPCR can be precise, reproducible, and absolute cannot be
readily extrapolated to the measurement of RNA [30]. The RT
step introduces an additional source of variability. It is a well-
documented fact that RT does not convert all RNA to cDNA
[32,33]. RT inefficiency and variability may account for the
majority of measurement divergence, especially given that qPCR
has been shown to be extremely sensitive and efficient [34,35]. In
addition, several studies have shown that RT reaction components
may have a reversible inhibitory effect on the subsequent qPCR,
the magnitude of which depends on the RT system
[17,27,36,37,38]. While it would be hoped that in the one-step
kits investigated in this study the RT components would have
minimal effect on the PCR step, one cannot rule out the possibility
that as well as RNA not being converted to cDNA, failed
subsequent amplification of the cDNA may also explain the
underestimation.
In our recent study, we documented a dPCR phenomenon
termed molecular dropout [39]. This event is characterised as a
failure to detect the presence of a target molecule during dPCR. In
other words, the target molecule is present in the partition but is
not amplified. Given this precedent, it is therefore plausible to
assume that molecular dropout, either at the cDNA or RNA stage
of the RT-dPCR process, on a much larger scale to that measured
by dPCR alone, may partly explain our findings. Moreover, it is
possible that different enzymes may be affected to different degrees
by this phenomenon. Several factors may contribute to molecular
dropout including assay sensitivity, reagent inhomogeneity,
template complexity and matrix effects (e.g. inhibition).
Template secondary structure and position of the assay is known
to impact on the RT-qPCR reaction [34] and may contribute to
this molecular dropout. The potential impact of template
secondary structure was assessed [21,22] to evaluate whether this
could be a cause for molecular drop out and determine positional
influences contributing to assay performance. All templates
displayed a degree of secondary structure within the amplicon
region (Figure S1). When concentrating on the regions comple-
mentary to the reverse primer (used in the RT to prime cDNA
synthesis), all templates exhibited some degree of stem-loop
structures. However, the 39 ends of the reverse primer comple-
mentary region showed differing secondary structures. For
example the 39 end within ERCC-25 was within an open (loop)
structure while for ERCC-99, the final base was designed to bind
to a closed (stem) region (Figure S1 D & F). Given that the primers
are extended from the 39 end, this may explain why ERCC-25
consistently gave a higher value than ERCC-99 despite their being
present at the same copy number. The assay-specific bias observed
between kits for different external and endogenous targets maybe
in part explained by predicted template secondary structures and
this would also appear to be kit specific.
The recommendation from the MIQE guidelines [34] that RT
primers be designed to stem loops to improve qPCR maybe a
initial UV quantification of stock and predicted target levels following volumetric dilutions. (A) & (B) dPCR sensitivity. (B) Focus on lowest level target
dilutions. Error bars: 95% Confidence intervals. (C) Precision of dPCR quantification compared to UV.
doi:10.1371/journal.pone.0075296.g003
Figure 4. Evaluation of Reverse Transcriptases. Three different one-step RT-qPCR kits were compared in different duplex formats, by dPCR.
Quantification for external (ERCC-25 and ERCC-99) and endogenous (MMP1 and UBC) targets was evaluated. ERCC-25 with ERCC-99 (duplex A), UBC
with MMP1 (duplex B), and ERCC-25 with UBC (duplex C). In the key/tabulated values, the assay in brackets is the duplex partner for the assay whose
positive partition values are being displayed. Error bars: 95% Confidence intervals. n = 3 replicate panels, plus two replicate experiments.
doi:10.1371/journal.pone.0075296.g004
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particularly important consideration when performing RT-dPCR
to improve assay sensitivity. Further work is required to build on
the hypothesis that RNA structure will effect RT-dPCR sensitivity,
but our findings suggest reaction efficiency may in part reflect the
ability of an enzyme to negotiate strong secondary structures and
successfully progress the course of the reaction and that this is
specific to different kits.
There may be other factors contributing to RT yields. For
example, the samples used were sourced from cell line lysates. Co-
extracted inhibitors may affect different reverse transcriptases to
different degrees. Furthermore, components of total RNA, such as
rRNA and tRNA may additionally inhibit RTase efficiency [40],
by competing for reagents and producing undesired products.
However, the manufacturers claim that the RTase used in the
Invitrogen kit is not significantly inhibited by such total RNA
components. These considerations taken together may in part
explain the disparity displayed between different one-step RT-
qPCR kits.
As may be seen from this comparison, despite the accuracy
conferred by dPCR, analysis of RNA using RT-dPCR needs to be
approached with caution. While for RNA measurement the
precision of the RT-dPCR technique is high, it nonetheless
introduces increased variability into the measurement value than
dPCR alone [7]. The significant differences observed between kit
sensitivities, particularly for low abundance targets (MMP1),
highlight the importance of reagent choice and protocol consis-
tency as critical if data sets are to be meaningfully compared.
Furthermore, the inability to detect certain targets may be due to
the choice of RTase/kit and all experimental plans should
therefore be validated appropriately before embarking upon
studies analysing important samples.
For accurate RNA analysis by RT-dPCR it is possible that
unknown measurements should be properly correlated to an
appropriate measurement standard, with a well-defined value and
uncertainty [30,41,42,43]. It may also be the case that while,
unlike RT-qPCR, RT-dPCR may not need a calibration curve to
assign a value, some kind of calibration molecule will be required
to compensate for the assay/kit differences observed here. All
samples may be normalised to a calibrator sample, also known as a
reference sample, in a similar way as performed for relative
quantification by RT-qPCR. It is possible that in some cases where
assay bias is observed, only gene specific calibrators will be
appropriate. For accurate absolute quantification our data suggest
use of a calibrant sample, with an accurate assigned value, will
allow straightforward correction of dPCR data to account for
differences in enzyme efficiencies, inhibitors and molecular
dropout. Such dPCR-specific calibrant materials are yet to be
developed and approaches combining validated external and
endogenous control materials, as described here, represent a
possible strategy. The full power of this technique may only be
realised on their experimental incorporation.
Conclusion
This study has shown that dPCR is capable of making precise
measurements of synthetic and endogenous RNA molecules in a
complex RNA background. RT-dPCR quantification of RNA
targets was significantly lower than that derived from UV values
suggesting a possible underestimation bias. Furthermore, absolute
measurements differed between the three one-step kits assessed,
with bias in detection sensitivity. Linearity and precision were
sustained for duplex dPCR measurement of synthetic RNA using
the Ambion kit, while sensitivities differed between RNA targets.
dPCR is unencumbered by the restraints of calibration curve
measurements, however, the employment of dPCR-specific
calibrant materials (reference samples) would facilitate greater
accuracy for absolute quantification. Furthermore, use of the
TCM shows the applicability of RT-dPCR for the target-
dependent selection of suitable RT enzymes. This study is novel
in demonstrating application of RT-dPCR for absolute quantifi-
cation of RNA endogenous and synthetic targets. Our findings
give strong weight to the applicability of RT-dPCR to measure-
ment fields including RNA diagnostics and RNA viral measure-
ment.
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